interferon advanc colorect carcinoma assess activ toxic preclin data cytotox effect interferon ifn small studi patient advanc colorect cancer regimen ifn dose schedul pilot studi untreat patient metastat colorect carcinoma continu intraven IV infus day weekli bolu subcutan ifn unit time week evalu patient partial respons confid limit median respons durat month rang month seven patient minor respons ten stabl diseas common toxic stomat diarrhea neurotox patient gait disturb dizzi confus memori loss dementia toxic patient reduct ifn dose reduct dose combin ifn patient advanc colorect carcinoma activ regimen toxic observ respons rate superior program 